Dana-Farber Cancer Institute at Merrimack Valley — Methuen, Massachusetts

Dana-Farber Cancer Institute at Merrimack Valley is a clinical research site located in Methuen, Massachusetts, United States 01844.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Institute at Merrimack Valley has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma.

Sponsors: Dana-Farber Cancer Institute.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Methuen

Browse all research sites in Massachusetts · View every site in Methuen

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Institute at Merrimack Valley?

Dana-Farber Cancer Institute at Merrimack Valley has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Institute at Merrimack Valley conducted?

Dana-Farber Cancer Institute at Merrimack Valley has 2 clinical trials on record, with 2 currently active. Their work covers Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma.

Is Dana-Farber Cancer Institute at Merrimack Valley accredited by Crixeo Clinical Trials?

Dana-Farber Cancer Institute at Merrimack Valley has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Cancer Institute at Merrimack Valley?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.